Binge-Eating Disorder And Attention Deficit Hyperactivity Disorder

Binge-Eating Disorder And Attention Deficit Hyperactivity Disorder.
A slip occupied to treat attention-deficit/hyperactivity disorder (ADHD) may also help treat binge-eating disorder, prior research suggests. At higher doses tested, the prescription drug Vyvanse curtailed the extravagant food consumption that characterizes binge-eating disorder. Vyvanse (lisdexamfetamine dimesylate) is solely approved in the United States to touch on ADHD, and no drug has been approved to curb binge-eating disorder home. Binge-eating - only recently recognized by the psychiatric community as a exact disorder - is characterized by cyclical episodes of excessive food consumption accompanied by a sense of loss of control and subjective distress, the study authors noted.

It is also associated with obesity. "Right now the most commonly used medications are epilepsy drugs," said lessons co-author Dr James Mitchell, president of the Neuropsychiatric Research Institute in Fargo, ND. "And they do support patients to eat well and cut down on weight info. However, their inconsiderable effect profiles are not great, with their impact on cognitive mental impairment in separate making them difficult for many patients to tolerate".

What Mitchell found most impressive in the new study on Vyvanse was the drug's effectiveness and that it was "very well tolerated". The 14-week study, reported in the Jan 14, 2015 online copy of JAMA Psychiatry, was funded by Shire Development, LLC, the producer of Vyvanse. The researchers tracked outcomes in the midst roughly 260 patients with moderate to inclement binge-eating disorder between 2011 and 2012. All of the participants were between 18 and 55 years old, and none had a diagnosis of any additional psychiatric disorders, such as ADHD, anorexia or bulimia.

The volunteers were divided into four groups for 11 weeks. The to begin organization received 30 milligrams (mg) of Vyvanse daily, while the surrogate and third groups started with 30 mg a day, increasing to 50 mg or 70 mg (respectively) within three weeks. A fourth gathering took an immobilized placebo pill. Vyvanse did not appear to help curtail binge eating at the lowest dosage. But subjects taking the higher doses experienced a bigger drop in the number of days they binged each week compared with the placebo group, the researchers found.